Vascular calcification is a frequent cause of morbidity and mortality in patients with CKD and the general population. The common association between vascular calcification and osteoporosis suggests a link between bone and vascular disorders. Because microRNAs (miRs) are involved in the transdifferentiation of vascular smooth muscle cells into osteoblast-like cells, we investigated whether miRs implicated in osteoblast differentiation and bone formation are involved in vascular calcification. Different levels of uremia, hyperphosphatemia, and aortic calcification were induced by feeding nephrectomized rats a normal or highphosphorus diet for 12 or 20 weeks, at which times the levels of eight miRs (miR-29b, miR-125, miR-133b, miR-135, miR-141, miR-200a, miR-204, and miR-211) in the aorta were analyzed. Compared with controls and uremic rats fed a normal diet, uremic rats fed a high-phosphorous diet had lower levels of miR-133b and miR-211 and higher levels of miR-29b that correlated respectively with greater expression of osteogenic RUNX2 and with lower expression of several inhibitors of osteoblastic differentiation. Uremia per se mildly reduced miR-133b levels only. Similar results were obtained in two in vitro models of vascular calcification (uremic serum and highcalcium and -phosphorus medium), and experiments using antagomirs and mimics to modify miR-29b, miR-133b, and miR-211 expression levels in these models confirmed that these miRs regulate the calcification process. We conclude that miR-29b, miR-133b, and miR-211 have direct roles in the vascular smooth muscle calcification induced by high phosphorus and may be new therapeutic targets in the management of vascular calcification.
A better knowledge of the pathogenesis of vascular calcification is essential, because it is a frequent cause of morbidity and mortality in the general population but especially, patients with CKD. Moreover, vascular calcification is frequently associated to bone mass disorders, which suggests that factors involved in the regulation of both entities could be linked. 1, 2 Vascular smooth muscle cells (VSMCs) have the same mesenchymal origin as osteoblasts, and they are able, in the presence of several stimuli, including uremia, to transdifferentiate into osteoblastic cells in response to signals coming from the internal milieu, extracellular matrix components, and biochemical and physical factors. 3, 4 This phenotypic modulation is tightly regulated and involves the loss of expression of several muscle-related proteins of the VSMCs and the gain of expression of bone-related proteins accompanied by macroscopic structural changes, such as calcifications. [5] [6] [7] A few recent studies have shown that some microRNAs (miRs) are new potential players in the differentiation of VSMCs into osteoblast-like cells, [8] [9] [10] although their role in the development of calcification is not completely clear. miRs are small (approximately 22 nucleotides), noncoding, single-stranded RNAs that mediate post-transcriptional gene silencing by binding to sites of antisense complementarity in 39 untranslated regions of target mRNAs. miRs are involved in crucial biologic processes, including cell proliferation and differentiation as well as tissue development. 11, 12 Recent studies have discovered that multiple miRs are important regulators of bone-related genes, including essential transcription factors such as Runt-related transcription factor 2 (RUNX2), the main transcription factor required for osteoblast differentiation. 13 Several miRs act as negative regulators of osteoblast differentiation and subsequent mineralization through their capacity to silence key transcription factors of the osteogenesis, such as RUNX2, 14, 15 Osterix, 16 or distal-less homeobox 5. 17 In contrast, some miRs promote osteogenesis by direct downregulation of multiple inhibitors of osteoblastic differentiation. 18 Thus, the aim of this study was to investigate both in vivo and in vitro the role of several miRs already implicated in osteoblast differentiation and bone formation in the process of vascular calcification.
RESULTS

Altered miR Levels in Aortas of Chronic Renal Failure Rats
In the in vivo model, all nephrectomized rats showed timedependent increases in serum levels of urea and creatinine compared with the control group (Table 1 ). In addition, serum P and parathyroid hormone (PTH) increased with time in chronic renal failure (CRF) rats fed a high-phosphorus diet (HPD) compared with both the control group and their respective normal-phosphorus diet (NPD) groups. Also, a significant time-dependent increase in Ca in the aorta was seen in CRF rats fed an HPD ( Figure 1 ) compared with either the control group or the respective NPD-fed group. Similar results were obtained for some osteoblastic markers, such as alkaline phosphatase (ALP) and osteocalcin (data not shown). Gene expression analysis of eight miRs potentially involved in osteoblastic differentiation (miR-29b, miR-125, miR-133b, miR-135, miR-141, miR-200a, miR-204, and miR-211) showed an increased expression of miR-29b, whereas the expressions of miR-133b and miR-211 were decreased in the aortas of the CRF rats fed an HPD compared with either the control group or the CRF groups fed an NPD (Table 2) . A significant lesser decrease in miR-133b levels was also observed in the aortas of CRF groups fed an NPD. There were no significant differences in the levels of the other miRs.
RUNX2, a target gene for the downregulated miRs (miR133b and miR-211), 15 showed a significant and time-dependent increased expression (2.40-and 2.91-fold over control at 12 and 20 weeks, respectively) ( Figure 2A ), whereas activin A receptor type IIA (ACVR2A), b-catenin interacting protein 1 (CTNNBIP1), and histone deacetylase 4 (HDAC4), known target genes for the upregulated miR (miR-29b), 18 showed a significant and time-dependent decreased expression ( Figure  2 , B-D, respectively) exclusively in the aortas of the CRF rats fed an HPD compared with both control and CRF rats from the same groups fed an NPD. Only minor increases in RUNX2 levels were observed in CRF rats fed an NPD (1.38-and 1.63-fold over control at 12 and 20 weeks, respectively) ( Figure 2A ).
miR-29b, miR-133b, and miR-211 Are Regulated by Uremic Serum In Vitro As a first in vitro approximation model, primary VSMCs cultured with media supplemented with 15% serum from uremic rats showed a significant increase in both mineralization measured as Ca deposition after 4 and 8 days of culture ( Figure 3A ) and ALP activity (data not shown). In this in vitro model, the analysis of the expression of the three miRs regulated in the in vivo model (miR-29b, miR-133b, and miR-211) as well as that of their target genes (RUNX2, ACVR2A, CTNNBIP1, and HDAC4) showed the same pattern of expression observed in CRF rats fed an HPD ( Figure 3 , B-D, respectively).
miR-29b, miR-133b, and miR-211 Are Regulated by High Phosphorus In Vitro To specifically address the effect of high P in the vascular calcification process, more precise calcifying conditions were used, growing VSMCs with medium supplemented with 2 mM Ca and 3 mM P. In this calcifying medium, VSMCs showed a significant increase in mineralization after 4 days of culture, which was measured as Ca content and Alizarin red staining, reaching the highest calcification level at day 8 ( Figure 4A ). ALP activity was increased in parallel to Ca content (data not shown). In this model, under calcifying conditions, the expression of miR-29b increased and the expressions of miR-133b and miR-211 decreased in calcifying conditions ( Figure  4B ), reproducing the behavior in the in vivo and in vitro cultures with uremic serum. In addition, the expression patterns of the studied target genes followed those in the previous models: RUNX2 increased ( Figure 4C ), whereas the expressions of the inhibitors All miRs were corrected by small nuclear ribonucleic acid U6 levels and adjusted for the value in the control group, which was set to one. Data represent means6SD. , CTNNBIP1 , and HDAC4, respectively) in the aortas of control and CRF rats after 12 and 20 weeks fed an NPD or an HPD. Control, nine rats; CRF 12w NPD, nine rats; CRF 12w HPD, nine rats; CRF 20w NPD, eight rats; CRF 20w HPD, seven rats. Data represent means6 SD. GAPDH, glyceraldehide-3-phosphate-dehydrogenase; R.U., relative units. *P,0.05 versus control; # P,0.05 versus the same group on an NPD.
of bone mineralization ACVR2A, CTNNBIP1, and HDAC4 decreased ( Figure 4D ).
Effects of miR-29b, miR-133b, and miR-211 in Calcification Models In Vitro
To show that miR-29b, miR-133b, and miR-211 play a direct role in the regulation of VSMCs calcification, two in vitro approaches were followed. In the first approach, we recreated the changes in miRs levels by overexpressing miR-29b or blocking miR-133b and miR-211 in VSMCs (Table 3) . A significant increase in Ca deposition was observed in three conditions ( Figure 5A ) accompanied by increased expression of RUNX2 when miR-133b or miR-211 was blocked ( Figure 5B ) and decreased expressions of CTNNBIP1, ACVR2A, and HDAC4 when miR-29b was overexpressed ( Figure 5C ). In a second approach, we used the two recognized in vitro models of calcification (uremic serum and high load of P) after preventing changes in miRs levels to analyze their functional effect on calcification. VSMCs cultured in either condition were transfected with an antagomir to miR-29b to inhibit its expression or pre-miR-133b or pre-miR-211 to force the expression of miR-133b or miR-211, respectively (Table  3 ). In these transfected VSMCs, the increase in Ca content stimulated by uremic serum was slightly prevented with the three miRs ( Figure 6A) , with a clear effect in the target genes RUNX2 ( Figure 6B ), ACVR2A, and CTNNBIP1 ( Figure 6C ). However, the increase in Ca content stimulated by high Ca and P was greatly prevented in all cases ( Figure 6D) ; also, the increase in ALP activity was prevented (data not shown). In this last model, the overexpression of miR-133b and miR-211 prevented the induction of their target gene RUNX2 compared with cells transfected with a negative control (scrambled) ( Figure 6E ). When miR-29b was downregulated, increased expression (prevention of the downregulation) of some of their target genes (ACVR2A and CTNNBIP1) was observed in the cells cultured with calcifying medium ( Figure 6F ). We did not find statistically significant differences in Ca content ( Figure 6G ) or stimulation or repression of the target genes ( Figure 6 , H and I) when we transfected three miRs simultaneously compared with individual transfections.
Serum Levels of miR-29b, miR-133b, and miR-211 To find out whether these miRs (miR-29b, miR-133b, and miR-211) would serve as serum biomarkers of vascular calcification in rats, serum levels were analyzed in all calcified groups. No significant differences between control and calcified rats were found for any of three miRs analyzed (Table 4) .
DISCUSSION
The phenotypic diversity of VSMCs seems to depend on both innate genetic programs and signals from the environment. 19 However, the mechanisms of the phenotypic modulation and osteogenic differentiation of VSMCs are not completely understood, and they are the subject of intense research. Recent studies have described multiple miRs as important regulators of bone-related genes. 10, 20 In this study, it has been shown that three miRs previously implicated in different steps of bone formation and differentiation (miR-29b, miR-133b, and miR-211) are also endogenous regulators of VSMCs calcification and therefore, could be mediators of vascular calcification ( Figure 7 ).
In the first approach, eight miRs (miR29b, miR-125, miR-133b, miR-135, miR-141, miR-200a, miR-204, and miR-211) were selected to be examined using an in vivo model of vascular calcification on the basis of nephrectomized rats fed an HPD. Previous studies have shown in rats that just CRF is not enough to induce vascular calcification. In fact, other additional stimuli are necessary, such as an HPD 21, 22 or calcitriol. 23 In addition, rats with normal renal function under the same stimulus may exhibit certain alterations in serum, but they do not calcify, despite an HPD. 21 The eight selected miRs have a known role in the osteogenic differentiation in bone, and therefore, their function in the VSMCs transdifferentiation into osteoblast-like cells was investigated. It is known that miR-133, miR-135, miR-204, and miR-211 act as negative regulators of osteoblast differentiation and subsequent mineralization, functionally inhibiting differentiation of osteoprogenitorsby attenuating the essential transcription factor RUNX2. 24 Specifically, miR-133 negatively regulates RUNX2 by direct targeting of its 39 untranslated region. 9 Furthermore, miR-133 inhibits not only translation of RUNX2 but also, in cooperation with miR-135, bone morphogenetic protein 2-induced osteogenic differentiation in mouse myoblasts. 14 Moreover, miR-133 was absent in the committed osteoblast precursor cell line from mouse calvaria MC3T3. All of these reports suggest that miR-133 represents a key mechanism for suppressing the osteoblast phenotype in nonosseous mesenchymal cells. Our results in VSMCs and CRF in vivo showed lower levels of miR-133b with hyperphosphatemia, with an associated increase in RUNX2 levels in the calcification process. Additionally, a slight decrease in miR-133b levels was attributed to the uremic status. The direct implication of this miR in modulating RUNX2 expression was further shown through its directed overexpression, which resulted in decreased RUNX2 expression. In the case of miR-211, an endogenous attenuator of this transcription factor, the effect in Ca deposition did not correlate in proportion with the effect in RUNX2, suggesting that miR-211 could exert its effects on calcification through additional pathways. In fact, miR-211 was described to regulate members of the Wnt-signaling pathway, a recognized inducer of osteogenesis. 25 Table 3 . Relative levels of miR-29b, miR-133b, and miR-211 reached in VSMCs transfected with the corresponding pre-miRs and antagomirs, cultured for 4 days in basal medium (DMEM), DMEM + 15% uremic serum, and DMEM + 2 mM Ca + 3 mM P, and determined by RT-qPCR Not all miRs are functional inhibitors of osteoblastogenesis. In fact, miR-29b was reported significantly upregulated during osteoblastic differentiation, promoting osteogenesis through direct downregulation of multiple inhibitors of osteoblastic differentiation, including ACVR2A, CTNNBIP1, and HDAC4. 18 The CRF animal model fed an HPD used in our study supports the reported role of miR-29b to modulate the transdifferentiation of VSMCs into osteoblast-like cells.
In summary, in our in vivo model of CRF and high P, only three of eight miRs studied (miR-29b, miR-133b, and miR-211) showed changes in their expression that were associated with RUNX2 expression among other osteogenic-modulating genes. However, we cannot discard that the other miRs assayed (miR-125, miR-135, miR-141, miR-200a, and miR-204) might be mediators in the calcification process not triggered by high P.
In vitro models reproducing our in vivo results further supported the contribution of these three miRs to calcification. Because uremic serum from patients on dialysis increases the expression of inducers of calcification, such as RUNX2, and consequently, the VSMCs calcification, 26 in the first in vitro model, calcification in VSMCs was induced by culturing cells with uremic serum from CRF rats. VSMCs exposed to uremic serum corroborated the decreased expression of miR-133b observed in vivo. In the uremic state, several known and unknown uremic toxins and inflammatory cytokines, including members of the TNF-a family, are capable of inducing osteogenic genes. [27] [28] [29] Furthermore, patients with CKD frequently have higher serum P levels, and they are more prone to develop severe vascular calcification. Clearly, another factor that may explain the observed effects of the uremic serum could be the slight increase in P levels, which we could see in our in vitro uremic model showing increased expression of miR-29b and decreased expression of miR-211 but did not observe in uremic and not hyperphosphatemic rats. Therefore, the slight increase in P may aggravate the in vitro VSMCs calcification already triggered by the uremic toxins. 30 In fact, the effects seen in the in vitro uremic model are in the same direction as those observed in the high-Ca and -P model, although less pronounced. Both models confirmed a direct effect of the miRs in some of their target genes. However, our experimental design does not allow a greater gene inhibition with the pool of miRs (even in interfering experiments with small interfering RNAs, gene inhibition is never complete). Similarly, overexpression of a gene should have a limit, and we were not able to reach a greater expression, even with the blockade of several exogenous miRs. In any case, our results suggest that these regulatory molecules contribute, in part, to the mechanism implicated in the phenotypic changes and mineralization of VSMCs. However, we cannot rule out the effect on miRs levels of osteogenic transcription factors, such as Osterix, which are known to downregulate miR-204/211, 31 stabilizing a regulatory feedback loop.
Additional support of the translational relevance of our findings would be obtained by examining whether the levels of these candidate miRs in the arteries of patients with CKD correlate with the degree of calcification. 32 Undoubtedly, this analysis is beyond the shape of this study. In addition, it would be important to analyze the effect of these miRs at the protein level, because miRs also work by inhibiting translation.
With the current diagnostic techniques relying mainly on imaging techniques, vascular calcification is observed when it is already well established. The identification of noninvasive biomarkers of subclinical vascular calcification would allow early interventions to slow its progression to clinical calcification. Blood sampling is a minimally invasive method to identify biomarkers. In various disease conditions, the profiles of circulating miRs vary with the degree of disease progression. [33] [34] [35] At present, no circulating biomarkers are available for the diagnosis of subclinical vascular calcification, and this mainly relies on imaging techniques that allow evaluation of calcifications. However, great repercussions would result from finding a serum biomarker of early vascular calcification. Unfortunately, none of three miRs analyzed in our study fulfill the function of a biomarker, because no significant differences were found in their serum levels as calcification progressed. However, our search was limited to eight miRs. The complete regulatory network of several miRs reported to control osteogenesis by controlling RUNX2 36, 37 suggests that, in the future, a molecular signature of vascular calcification constituted by several miRs could be established. 38 In summary, our data show that high P upregulates miR-29b and downregulates miR-133b and miR-211, altering, as a consequence, the expression of several genes involved in VSMCs phenotypic modulation and osteogenic differentiation ( Figure  7) . These results support a key role of miR regulation in controlling osteoblastic differentiation. The possibility of using these miRs as therapeutic tools to prevent vascular calcification awaits animal models using miRs to target specific genes involved in vascular calcification.
CONCISE METHODS
In Vivo Study Animal Model of Vascular Calcification
The protocol was approved by the Laboratory Animal Ethics Committee of Oviedo University and adheres to the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The study was performed using 4-month-old (350-400 g) male Wistar rats (n=42). Rats were anesthetized using methoxifluorane, and CRF was carried out by 7/8 nephrectomy as previously detailed. 39 The CRF rats were divided in two groups: a group fed a standard rodent chow with an NPD (0.6% P, 0.6% Ca, and 20% protein content) and a group fed an HPD (0.9% P, 0.6% Ca, and 20% protein content; Panlab). An additional group of rats that was sham operated (normal renal function) and fed for 20 weeks with the standard rodent chow was also included in the study as the control group (n=9). The rats were housed in wire cages and received diet and water ad libitum. After 12 and 20 weeks, rats were euthanized using CO 2 anesthesia, and serum samples were drawn for analyses. Aortas were removed, washed two times with saline solution, and divided into three pieces: the first fragment was used for RNA extraction, the second fragment was used to determine Ca content, and the third fragment was fixed, embedded in paraffin, and sliced for the histologic studies.
Biochemical Markers
Serum urea, creatinine, Ca, and P were measured using a multichannel auto analyzer (Hitachi 717). Serum PTH was measured by ELISA (Rat Intact PTH ELISA Kit; Immutopics) following the manufacturer's protocols.
Aortic Calcification Analysis
The calcification of the abdominal aortas of the rats was analyzed by two methods: total Ca content and von Kossa staining. To determine the total Ca content, a piece of the abdominal aorta (the 2-cm segment proximal to the iliac bifurcation) was homogenized with an Ultraturrax (OmniHT) in 0.6 N HCl. After stirring at 4°C for 24 hours, samples were centrifuged. Ca content was determined in the supernatant by the o-cresolphtalein complexone method 40 (SigmaAldrich), and the pellet was resuspended in lysis buffer (125 mM Tris and 2% SDS, pH 6.8) for protein extraction and quantification by Lowry method (Bio-Rad). Ca content was normalized to total cell protein and expressed as micrograms of Ca per milligram of protein.
To perform von Kossa staining, another fragment of the abdominal aorta was embedded in methylmethacrylate (Sigma-Aldrich). Five sections 5-mm thick were obtained using a Polycut S Microtome (Reicher-Jung) and stained following von Kossa method.
Total RNA Isolation, cDNA Synthesis, and Quantitative PCR The third fragment of the abdominal aorta from the rats was homogenized in an Ultraturrax (OmniHT) in TRI Reagent (SigmaAldrich) following the manufacturer's instructions. Total RNA concentration and purity were quantified by UV-Vis Spectrophotometry (NanoDrop Technologies), which measured absorbance at 260 and 280 nm. Reverse transcription was performed with a High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems) following the manufacturer's instructions. Gene expression was measured by retrotranscription quantitative PCR (qPCR) using a Stratagene Mx3005P (Agilent Technologies). TaqMan qPCR amplification was performed with gene-specific primers (Gene Expression Assays; Applied Biosystems) for selected target genes of the regulated miRs: RUNX2, ACVR2A, CTNNBIP1, and HDAC4. Rat glyceraldehide-3-phosphate-dehydrogenase was used as the housekeeping gene. The relative quantitative evaluation of target genes was performed by comparing threshold cycles using the DD cycle threshold method. 41 Mature miR expression levels were also analyzed from total RNA using TaqMan miRNA Assays (Applied Biosystems) for rat miR-29b, miR-125, miR-133b, miR-135, miR-141, miR-200a, miR-204, and mi-R211 according to the manufacturer's instructions. qPCR was performed on the resulting cDNA using the appropriate TaqMan miRNA Gene Expression Assay. Endogenous rat small nuclear RNA U6 for tissue sample and exogenously added 4.5S for serum samples were used as references. The relative quantitative evaluation of target genes was performed by comparing threshold cycles using the DD cycle threshold method. 41 In Vitro Study Primary Cell Culture Primary VSMCs culture was obtained from aortas of healthy 2-month-old Wistar rats using explants. Briefly, 12 rats were euthanized using CO 2 anesthesia, and abdominal aortas were removed and placed immediately in ice-cold PBS with 100 units/ml penicillin and 100 mg/ml streptomycin (Biochrom AG). After washing with fresh PBS, aortas were cut lengthwise; the endothelial layer was removed carefully and subsequently cut into 2-to 3-mm 2 fragments (explants). The explants were then placed into fibronectin (10 mg/cm 2 ; Sigma-Aldrich) -coated six-well plastic culture dishes (Corning Costar) and immersed in a drop of DMEM (Lonza) supplemented with 20% FBS (HyClone). The explants were placed in a humidified incubator (5% CO 2 ) at 37°C until they were attached to the surface of the culture well. Then, an additional 1 ml serum-supplemented (20%) DMEM was added. After subconfluence, the tissue fragments were removed, and cells were enzymatically dispersed (0.25% trypsin and 1 mM EDTA), pooled, and counted with a Scepter 2.0 (Millipore). Cells were seeded (10 5 cells per plate) in 100-mm plates (Nunc) with serum-supplemented (10%) DMEM. Cells obtained by this method were identified as VSMCs by the following criteria: (1) the cells grew in the characteristic hill and valley pattern, and (2) immunostaining was positive for a-smooth muscle actin (mAb from Sigma-Aldrich). We used cells between passages 2 and 8 in three wells per condition, and the experiments were performed three times each.
Induction of Primary VSMCs Calcification
To induce VSMCs calcification, two different conditions were used. For the first condition, VSMCs were culture in DMEM supplemented with 15% uremic rat serum (a pool of sera from 8-week-old CRF rats containing 10.8 mg/dl Ca, 6.7 mg/dl P, and 898 pg/ml PTH). A control condition with 15% healthy rat serum (a pool of sera containing 10.4 mg/dl Ca, 3.6 mg/dl P, and 25 pg/ml PTH) was used for comparison. To confirm the effect of P, VSMCs were cultured in a second condition: DMEM F12 + 0.1% BSA with Ca (final concentration of 2 mM) and P (3 mM; calcifying medium). A control condition (DMEM F12 + 0.1% BSA; control medium) was used as a reference. In both cases, Ca deposition was determined 4 and 8 days after the addition of the stimuli.
Determination of Primary VSMCs Calcification
VSMCs calcification was determined by two methods: total Ca content and Alizarin red staining. For the first method, VSMCs were washed three times with PBS and decalcified with 0.6 N HCl at 4°C with gently shaking for 24 hours. Ca released from cell cultures into the supernatant was determined colorimetrically using the o-cresolphtaleine complexone method. 40 Cells were collected in lysis buffer (125 mM Tris and 2% SDS, pH 6.8) for protein extraction and quantification by the Lowry method (Bio-Rad). Ca content was normalized to total cell protein and expressed as micrograms Ca per milligram protein. For the second method, Ca deposits were stained with Alizarin red following a previously described procedure. 42 
Transfection with miR Antagomirs and Precursors
VSMCs were seeded at 5000 cells per cm 2 in six-well plates (Corning Costar). The next day, with 60%-70% confluence, cells were transfected. To force expressions of miR-29b, miR-133b, and miR-211, cells were transfected overnight with 500 pmol precursors of miR-29b, miR-133b, and miR-211 (pre-miR-29b, pre-miR-133b, and pre-miR-211, respectively; Ambion) using the DharmaFECT transfection reagent following the manufacturer's instructions. To inhibit miR-29b, miR-133b, and miR-211, cells were transfected with an antisense oligonucleotide (antagomir) of miR-29b, miR-133b, and miR-211 (500 pmol anti-miR-29b, anti-miR-133b, and anti-miR-211, respectively; Ambion). In the experiment to analyze the effect of modifying the expression of three miRs simultaneously, the amount of each miR mentioned above and the corresponding transfection reagent were used. Transfection using a scrambled sequence (miRNA Negative Control; Ambion) was used as a negative control with the same concentrations and exposure times. VSMCs were cultured for 4 days in control medium or two different calcifying media (DMEM + 15% uremic serum and DMEM + 2 mM Ca + 3 mM P), and then, Ca content and gene expression were assessed.
Statistical Analyses
Statistical comparisons between groups were carried out by one-way ANOVA and t test. The results were expressed as means6SD. Data from qPCR were transformed before mean and SD determination by dividing the values by the mean value of the control group. Differences were considered significant when P,0.05. All statistical analyses were performed using SPSS 17.0 for Windows.
